BLOOMFIELD, Conn., July 27, 2023 /PRNewswire/ -- In response to recent media misrepresentations, Cigna Healthcare, the health benefits provider of The Cigna Group (NYSE: CI), today shared information about one of its processes used to expedite payments to health care clinicians for a small number of relatively low-cost procedures. Cigna believes that the inaccurate portrayal of the PxDx – or "procedure to diagnosis" – process may lead to confusion or misunderstanding about how it works and how it is used.
Here are the facts about this claims review process:
More information about this claims review process is available here.
About Cigna Healthcare
Cigna Healthcare is a health benefits provider that advocates for better health through every stage of life. We guide our customers through the health care system, empowering them with the information and insight they need to make the best choices for improving their health and vitality. Products and services are provided exclusively by or through operating subsidiaries of The Cigna Group (NYSE:CI), including Cigna Health and Life Insurance Company, Connecticut General Life Insurance Company, Evernorth Health companies or their affiliates and Express Scripts companies or their affiliates. Such products and services include an integrated suite of health services, such as medical, dental, behavioral health, pharmacy, vision, supplemental benefits, and others. Learn more at cignahealthcare.com.
Media contact:
Justine Sessions
This email address is being protected from spambots. You need JavaScript enabled to view it.
860-810-6523
Last Trade: | US$339.19 |
Daily Change: | 4.19 1.25 |
Daily Volume: | 629,811 |
Market Cap: | US$94.340B |
October 31, 2024 September 12, 2024 September 12, 2024 August 01, 2024 |
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MOREClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB